Lyn Rees

Lyn Rees

Vorstandsvorsitzender bei NOVACYT

Vermögen: 14 579 $ am 31.05.2026

53 Jahre
Health Technology
Commercial Services
Finance

Profil

Lyn Dafydd Rees was the founder of BBI Animal Health Ltd., founded in 2006, where the title held was Managing Director.
Mr. Rees is also the founder of BBI Detection Ltd...
Current jobs include Chief Executive Officer & Executive Director at Novacyt SA since 2024, Chief Executive Officer at Novacyt UK Holdings Ltd. since 2024, Chief Executive Officer & Director at Yourgene Health Ltd. since 2018, Director at Yourgene Health UK Ltd. since 2019, Director at Delta Diagnostics (UK) Ltd. since 2019, and Director at Yourgene Genomic Services Ltd. since 2020.
Former jobs include Group Chief Executive Officer at BBI Diagnostics Group Ltd. from 1999 to 2018, Chief Executive Officer at BBI Diagnostics Group 2 Plc from 2009 to 2016, Chief Executive Officer at BBI Group Holding Ltd., Chief Executive Officer at BioNote, Inc., Director at British Biocell International Ltd., Director at Alchemy Laboratories Ltd., Director at BBI Enzymes UK Ltd., Director at BBI Enzymes Ltd., Non-Executive Director at Fortis Frontier Plc from 2019 to 2025, Managing Director at Venture Life Healthcare Ltd., Independent Non-Executive Director at Abingdon Health Plc from 2020 to 2022, Director at Scipac Ltd., Director at BBI Acquisition Ltd., Director at BBI Solutions OEM Ltd., Director at Alere BBI Holdings Ltd., Director at Eagle SPV 2 Ltd., Director at Eagle SPV 3 Ltd., Director at BBI Enzymes (USA) Ltd., Director at BBI Resources Ltd., Director at Novarum DX Ltd., and Marketing Manager-European Region at Shimano Europe BV from 1996 to 1999.
Education includes undergraduate degree from the University of Wales (Bangor).

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
31.12.2024 132’738 ( 0.41% ) 14 579 $ 31.05.2026

Aktive Positionen von Lyn Rees

UnternehmenPositionBeginn
YOURGENE HEALTH Vorstandsvorsitzender 04.07.2018
NOVACYT Vorstandsvorsitzender 01.05.2024
Direktor/Vorstandsmitglied 03.07.2020
Direktor/Vorstandsmitglied 25.04.2019
Direktor/Vorstandsmitglied 02.01.2019
Vorstandsvorsitzender 01.05.2024

Ehemalige bekannte Positionen von Lyn Rees

UnternehmenPositionEnde
FORTIS FRONTIER PLC Direktor/Vorstandsmitglied 30.11.2025
ABINGDON HEALTH PLC Direktor/Vorstandsmitglied 30.09.2022
Vorstandsvorsitzender 01.01.2018
░░░ ░░░░░░░░░░░ ░░░░░ ░ ░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░ ░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Lyn Rees im Detail an

Ausbildung von Lyn Rees

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

29

Beziehungen ersten Grades

30

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen30

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

BBI Enzymes UK Ltd.

BBI Enzymes Ltd.

Consumer Durables

Retail Trade

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Scipac Ltd.

Commercial Services

Finance

Health Technology

Process Industries

Finance

Health Technology

Finance

Commercial Services

Distribution Services

Process Industries

Commercial Services

Technology Services

Health Technology

Health Technology